UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 14)*
Advanced Medical, Inc.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
00754 C 10 1
(CUSIP Number)
Jonathan Klein, Esq.
Gordon Altman Butowsky Weitzen Shalov & Wein
114 West 47th Street, 20th Floor
New York, New York 10036
(212) 626-0800
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
August 2, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject
of this Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box //.
Check the following box if a fee is being paid with the
statement //. (A fee is not required only if the reporting
person: (1) has a previous statement on file reporting
beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership
of five percent or less of such class.) (See Rule 13d-7).
NOTE: Six copies of this statement, including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for
other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).
Page 1 of 6 Pages<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 00754 C 10 1 Page 1 of 6 Pages
1 NAME OF REPORTING PERSON
Jeffry M. Picower
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /x/
(b) //
3 SEC USE ONLY
4 SOURCE OF FUNDS*
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) //
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
30,277,946
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
30,277,946
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,277,946
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
71.2%
14 TYPE OF REPORTING PERSON*
IN
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 00754 C 10 1 Page 2 of 6 Pages
1 NAME OF REPORTING PERSON
Decisions Incorporated
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /x/
(b) //
3 SEC USE ONLY
4 SOURCE OF FUNDS*
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) //
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
30,277,946
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
30,277,946
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,277,946
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
71.2%
14 TYPE OF REPORTING PERSON*
CO
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 00754 C 10 1 Page 3 of 6 Pages
1 NAME OF REPORTING PERSON
JA Special Limited Partnership
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /x/
(b) //
3 SEC USE ONLY
4 SOURCE OF FUNDS*
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) //
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
0
8 SHARED VOTING POWER
30,277,946
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
30,277,946
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,277,946
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
//
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
71.2%
14 TYPE OF REPORTING PERSON*
PN
<PAGE>
SCHEDULE 13D - AMENDMENT NO. 14
This statement ("Statement") constitutes Amendment No. 14 to
the Schedule 13D filed with the Securities and Exchange Commission (the
"Commission") on April 7, 1989 (the "Original Filing"), as amended by (i)
Amendment No. 1 (the "First Amendment") filed with the Commission on June
5, 1989; (ii) Amendment No. 2 (the "Second Amendment") filed with the
Commission on May 18, 1990; (iii) Amendment No. 3 (the "Third Amendment")
filed with the Commission on March 1, 1991; (iv) Amendment No. 4 (the
"Fourth Amendment") filed with the Commission on April 12, 1991; (v)
Amendment No. 5 (the "Fifth Amendment") filed with the Commission on
November 27, 1991; (vi) Amendment No. 6 (the "Sixth Amendment") filed
with the Commission on April 12, 1993; (vii) Amendment No. 7 (the
"Seventh Amendment") filed with the Commission on January 4, 1994; (viii)
Amendment No. 8 (the "Eighth Amendment") filed with the Commission on
June 29, 1994; (ix) Amendment No. 9 (the "Ninth Amendment") filed with
the Commission on August 19, 1994; (x) Amendment No. 10 filed with the
Commission on September 14, 1994 (the "Tenth Amendment"); (xi) Amendment
No. 11 filed with the Commission on October 26, 1994 (the "Eleventh
Amendment"); (xii) Amendment No. 12 filed with the Commission on February
3, 1995 (the "Twelfth Amendment); and (xiii) Amendment No. 13 filed with
the Commission on December 4, 1995, concerning the common stock, par
value $.01 per share ("Common Stock"), of Advanced Medical, Inc., a
Delaware corporation (the "Issuer"). The Original Filing, the First
Amendment, the Second Amendment and the Third Amendment were filed on
behalf of Jeffry M. Picower, April C. Freilich and Decisions
Incorporated, a Delaware corporation ("Decisions"). The Fourth
Amendment, the Fifth Amendment, the Sixth Amendment, the Seventh
Amendment, the Eighth Amendment, the Ninth Amendment, the Tenth
Amendment, the Eleventh Amendment, the Twelfth Amendment, and the
Thirteenth Amendment were, and this Statement is, filed on behalf of Mr.
Picower, Ms. Freilich, Decisions and JA Special Limited Partnership, a
Delaware limited partnership ("JA Special", and collectively with Mr.
Picower, Ms. Freilich and Decisions, "Registrants").
Item 4. Purpose of Transaction
Item 4 is hereby amended to add the following:
The purpose of this filing is to report the transfer of all of
the Shares previously beneficially owned by Picower directly to
Decisions, who in turn transferred the Shares to JA Special, a limited
partnership of which Decisions is the general partner. As a result of
such transfer, JA Special may be deemed to directly beneficially own
30,277,946 Shares while Decisions and Picower may be deemed to indirectly
beneficially own 30,277,946 Shares.
Item 5 Interest in Securities of the Issuer
Item 5 is amended to add the following:
As of the close of business on August 7, 1996, Registrants may
be deemed to beneficially own in the aggregate 30,277,946 shares of
Common Stock, comprising approximately 71% of Common Stock, based upon
the Common Stock stated to be outstanding by the Issuer on Issuer's
filing on form 10-K for the fiscal year 1995, as of March 21, 1996.
Registrants may be deemed to have shared power to vote and
shared power to direct the disposition of 30,277,946 shares of Common
Stock.
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
Dated: August 7, 1996
/s/ Jeffry M. Picower
Jeffry M. Picower
/s/ April C. Freilich
April C. Freilich
DECISIONS INCORPORATED
By: /s/ April C. Freilich
April C. Freilich
President
JA SPECIAL LIMITED PARTNERSHIP
By: Decisions Incorporated
General Partner
By: /s/ April C. Freilich
April C. Freilich
President
